Pregnant women with hyperglycemia, including Hb A1c ≥5.7% and/or FPG ≥5.1 mmol/l in early pregnancy were randomized to early pregnancy or third-trimester treatment of GDM. This evidence concerns the gene GSTM1 and Hyperglycemia.